BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27417586)

  • 1. Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease.
    Wang L; Chen J; Zeng Y; Wei J; Jing J; Li G; Su L; Tang X; Wu T; Zhou L
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1989-96. PubMed ID: 27417586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: a case control study.
    Lv X; Zhang Y; Rao S; Liu F; Zuo X; Su D; Wang M; Xia M; Guo H; Feng D; Hong C; Li D; Ma W; Ouyang P; Li X; Feng X; Yang Y; Ling W; Qiu J
    Lipids Health Dis; 2012 Oct; 11():128. PubMed ID: 23036009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.
    Trégouët DA; König IR; Erdmann J; Munteanu A; Braund PS; Hall AS; Grosshennig A; Linsel-Nitschke P; Perret C; DeSuremain M; Meitinger T; Wright BJ; Preuss M; Balmforth AJ; Ball SG; Meisinger C; Germain C; Evans A; Arveiler D; Luc G; Ruidavets JB; Morrison C; van der Harst P; Schreiber S; Neureuther K; Schäfer A; Bugert P; El Mokhtari NE; Schrezenmeir J; Stark K; Rubin D; Wichmann HE; Hengstenberg C; Ouwehand W; ; ; Ziegler A; Tiret L; Thompson JR; Cambien F; Schunkert H; Samani NJ
    Nat Genet; 2009 Mar; 41(3):283-5. PubMed ID: 19198611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A solute carrier family 22 member 3 variant rs3088442 G→A associated with coronary heart disease inhibits lipopolysaccharide-induced inflammatory response.
    Li L; He M; Zhou L; Miao X; Wu F; Huang S; Dai X; Wang T; Wu T
    J Biol Chem; 2015 Feb; 290(9):5328-40. PubMed ID: 25561729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case-Control Study of the Relationship Between SLC22A3-LPAL2-LPA Gene Cluster Polymorphism and Coronary Artery Disease in the Han Chinese Population.
    Song ZK; Cao HY; Wu HD; Zhou LT; Qin L
    Iran Red Crescent Med J; 2016 Jun; 18(6):e35387. PubMed ID: 27621937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHACTR1 and SLC22A3 gene polymorphisms are associated with reduced coronary artery disease risk in the male Chinese Han population.
    Zhao Q; Wei H; Liu D; Shi B; Li L; Yan M; Zhang X; Wang F; Ouyang Y
    Oncotarget; 2017 Jan; 8(1):658-663. PubMed ID: 27893421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between the LPA gene polymorphism and coronary artery disease in Chinese Han population.
    Song ZK; Wu HD; Cao HY; Qin L
    Biomed Res Int; 2014; 2014():370670. PubMed ID: 24790998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MEF2A and SLC22A3-LPAL2-LPA gene polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients.
    Al-Eitan LN; Almasri AY; Alnaamneh AH; Mihyar A
    PLoS One; 2023; 18(11):e0294226. PubMed ID: 37948393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymorphism in the ABCG1 promoter is functionally associated with coronary artery disease in a Chinese Han population.
    Xu Y; Wang W; Zhang L; Qi LP; Li LY; Chen LF; Fang Q; Dang AM; Yan XW
    Atherosclerosis; 2011 Dec; 219(2):648-54. PubMed ID: 21722899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the association of rs12040273 with susceptibility and severity of coronary artery disease in a Chinese Han population.
    Yang B; Yan S; Yan J; Li Y; Khurwolah MR; Wang L; Chen Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):10. PubMed ID: 29351739
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Song ZK; Cao HY; Wu HD; Zhou LT; Qin L
    Biomed Res Int; 2017; 2017():4138376. PubMed ID: 29457025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk.
    Ronald J; Rajagopalan R; Cerrato F; Nord AS; Hatsukami T; Kohler T; Marcovina S; Heagerty P; Jarvik GP
    Stroke; 2011 Jan; 42(1):2-9. PubMed ID: 21127300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
    Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL
    Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency.
    Cui G; Li Z; Li R; Huang J; Wang H; Zhang L; Ding H; Wang DW
    J Am Coll Cardiol; 2014 Jul; 64(3):267-77. PubMed ID: 25034063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic variant near adaptor-related protein complex 2 alpha 2 subunit gene is associated with coronary artery disease in a Chinese population.
    Wang S; Ma Z; Zhang Y; Ding Y; Chen Z; Wang L
    BMC Cardiovasc Disord; 2018 Aug; 18(1):161. PubMed ID: 30086706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of genetic variants at TTC32-WDR35 gene cluster with coronary artery disease in Chinese Han population.
    Xu Y; Zhuo Y; Ye M; Li M; Tang X; Zhou L
    J Clin Lab Anal; 2021 Feb; 35(2):e23594. PubMed ID: 33009702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of significant associations between single nucleotide polymorphisms in LPAL2-LPA genetic region and all cancer incidence and mortality in Japanese population: The Japan public health center-based prospective study.
    Mieno MN; Yamasaki M; Kuchiba A; Yamaji T; Ide K; Tanaka N; Sawada N; Inoue M; Tsugane S; Sawabe M; Iwasaki M
    Cancer Epidemiol; 2023 Aug; 85():102395. PubMed ID: 37321067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.
    Anderson JL; Knight S; May HT; Horne BD; Bair TL; Huntinghouse JA; Rollo JS; Muhlestein JB; Carlquist JF
    Am J Cardiol; 2013 Sep; 112(6):799-804. PubMed ID: 23735648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
    Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
    BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.